Renaissance Technologies
IMGN

Renaissance Technologies’s Immunogen Inc IMGN Stock Holding History

Renaissance Technologies’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,631,240
Closed -$48.4M – 4218
2023
Q4 		$48.4M Buy
1,631,240
+896,600
+122% +$17.9M 0.07% 307
2023
Q3 		$11.7M Sell
734,640
-483,400
-40% -$8.04M 0.02% 833
2023
Q2 		$23M Buy
1,218,040
+1,138,900
+1,439% +$13.4M 0.03% 615
2023
Q1 		$304K Buy
+79,140
New +$337K ﹤0.01% 3115
2022
Q4 		– Sell
-1,705,140
Closed -$8.15M – 4507
2022
Q3 		$8.15M Buy
1,705,140
+256,400
+18% +$1.35M 0.01% 1140
2022
Q2 		$6.52M Sell
1,448,740
-13,600
-0.9% -$59.1K 0.01% 1368
2022
Q1 		$6.96M Buy
1,462,340
+244,953
+20% +$1.36M 0.01% 1365
2021
Q4 		$9.03M Buy
1,217,387
+75,547
+7% +$470K 0.01% 1123
2021
Q3 		$6.47M Sell
1,141,840
-942,250
-45% -$5.44M 0.01% 1303
2021
Q2 		$13.7M Buy
2,084,090
+220,750
+12% +$1.54M 0.02% 965
2021
Q1 		$15.1M Sell
1,863,340
-2,372,626
-56% -$19.4M 0.02% 940
2020
Q4 		$27.3M Sell
4,235,966
-2,253,173
-35% -$13.1M 0.03% 605
2020
Q3 		$23.4M Sell
6,489,139
-3,176,000
-33% -$12.8M 0.02% 664
2020
Q2 		$44.5M Sell
9,665,139
-1,350,990
-12% -$5.75M 0.04% 469
2020
Q1 		$37.6M Buy
11,016,129
+308,990
+3% +$1.35M 0.04% 474
2019
Q4 		$54.7M Buy
10,707,139
+2,184,100
+26% +$7.41M 0.04% 491
2019
Q3 		$20.6M Buy
8,523,039
+1,600,399
+23% +$4.25M 0.02% 942
2019
Q2 		$15M Sell
6,922,640
-121,000
-2% -$286K 0.01% 1142
2019
Q1 		$19.1M Buy
7,043,640
+861,500
+14% +$3.73M 0.02% 999
2018
Q4 		$29.7M Sell
6,182,140
-130,500
-2% -$792K 0.03% 666
2018
Q3 		$59.8M Sell
6,312,640
-212,660
-3% -$2.04M 0.06% 373
2018
Q2 		$63.5M Buy
6,525,300
+1,719,360
+36% +$18.1M 0.07% 342
2018
Q1 		$50.6M Buy
4,805,940
+3,712,700
+340% +$36.7M 0.06% 441
2017
Q4 		$7.01M Buy
1,093,240
+568,900
+108% +$3.51M 0.01% 1601
2017
Q3 		$4.01M Sell
524,340
-198,000
-27% -$1.32M ﹤0.01% 1902
2017
Q2 		$5.14M Sell
722,340
-755,606
-51% -$3.46M 0.01% 1699
2017
Q1 		$5.72M Sell
1,477,946
-1,003,794
-40% -$2.93M 0.01% 1596
2016
Q4 		$5.06M Sell
2,481,740
-21,600
-0.9% -$43.4K 0.01% 1662
2016
Q3 		$6.71M Buy
2,503,340
+536,200
+27% +$1.56M 0.01% 1419
2016
Q2 		$6.06M Buy
+1,967,140
New +$12.3M 0.01% 1478
2016
Q1 		– Sell
-38,040
Closed -$516K – 3573
2015
Q4 		$516K Sell
38,040
-355,400
-90% -$4.37M ﹤0.01% 2724
2015
Q3 		$3.78M Buy
+393,440
New +$5.75M 0.01% 1573
2015
Q1 		– Sell
-162,840
Closed -$993K – 3391
2014
Q4 		$993K Sell
162,840
-207,606
-56% -$1.9M ﹤0.01% 2126
2014
Q3 		$3.92M Sell
370,446
-44,994
-11% -$509K 0.01% 1291
2014
Q2 		$4.92M Buy
+415,440
New +$5.21M 0.01% 1216

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Renaissance Technologies's IMGN Position: Q1 2024 in Review

Renaissance Technologies sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,631,240 shares — an estimated $48.4M sold.

Renaissance Technologies first reported a position in IMGN in Q2 2014 and held it in 35 quarters. The position peaked at $63.5M in Q2 2018. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Renaissance Technologies reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Renaissance Technologies sold 1,631,240 Immunogen Inc shares in Q1 2024, an estimated $48.4M.
  • Renaissance Technologies first reported a position in Immunogen Inc in Q2 2014 and held it in 35 quarters.
  • Renaissance Technologies's Immunogen Inc position peaked at $63.5M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.